OKDBV Stock Overview
Provides healthcare and wellbeing products primarily in Sweden and Finland.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Oriola Oyj Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.97 |
52 Week High | €1.17 |
52 Week Low | €0.85 |
Beta | 0.61 |
11 Month Change | 6.35% |
3 Month Change | 0.83% |
1 Year Change | -12.99% |
33 Year Change | -50.05% |
5 Year Change | -51.11% |
Change since IPO | -50.21% |
Recent News & Updates
Recent updates
Oriola Oyj Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jul 21Oriola Oyj (HEL:OKDBV) Is Paying Out A Larger Dividend Than Last Year
Feb 19Oriola Oyj (HEL:OKDBV) Is Increasing Its Dividend To €0.06
Feb 19Oriola Oyj (HEL:OKDBV) Has Announced That It Will Be Increasing Its Dividend To €0.04
Feb 20Oriola Oyj (HEL:OKDBV) Is Finding It Tricky To Allocate Its Capital
Jun 07Oriola Oyj (HEL:OKDBV) Shares Could Be 25% Below Their Intrinsic Value Estimate
Mar 26Oriola Oyj (HEL:OKDBV) Is About To Go Ex-Dividend, And It Pays A 1.4% Yield
Mar 12Are Investors Concerned With What's Going On At Oriola Oyj (HEL:OKDBV)?
Mar 06Oriola Oyj Just Missed Earnings - But Analysts Have Updated Their Models
Feb 20Should You Be Worried About Oriola Oyj's (HEL:OKDBV) 4.6% Return On Equity?
Feb 17What Type Of Shareholders Own The Most Number of Oriola Oyj (HEL:OKDBV) Shares?
Feb 01Does Oriola Oyj's (HEL:OKDBV) Statutory Profit Adequately Reflect Its Underlying Profit?
Jan 19Are Dividend Investors Getting More Than They Bargained For With Oriola Oyj's (HEL:OKDBV) Dividend?
Jan 06Is Oriola Oyj (HEL:OKDBV) A Risky Investment?
Dec 24An Intrinsic Calculation For Oriola Oyj (HEL:OKDBV) Suggests It's 37% Undervalued
Dec 12How Much Did Oriola Oyj's(HEL:OKDBV) Shareholders Earn From Share Price Movements Over The Last Five Years?
Nov 29Shareholder Returns
OKDBV | FI Healthcare | FI Market | |
---|---|---|---|
7D | 0.4% | 2.2% | 0.6% |
1Y | -13.0% | -4.2% | -7.9% |
Return vs Industry: OKDBV underperformed the Finnish Healthcare industry which returned -4.6% over the past year.
Return vs Market: OKDBV underperformed the Finnish Market which returned -8.8% over the past year.
Price Volatility
OKDBV volatility | |
---|---|
OKDBV Average Weekly Movement | 3.9% |
Healthcare Industry Average Movement | 4.7% |
Market Average Movement | 4.3% |
10% most volatile stocks in FI Market | 8.8% |
10% least volatile stocks in FI Market | 2.6% |
Stable Share Price: OKDBV has not had significant price volatility in the past 3 months.
Volatility Over Time: OKDBV's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 815 | Katarina Gabrielson | oriola.com |
Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services.
Oriola Oyj Fundamentals Summary
OKDBV fundamental statistics | |
---|---|
Market cap | €179.32m |
Earnings (TTM) | -€23.30m |
Revenue (TTM) | €1.56b |
0.1x
P/S Ratio-7.6x
P/E RatioIs OKDBV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
OKDBV income statement (TTM) | |
---|---|
Revenue | €1.56b |
Cost of Revenue | €1.40b |
Gross Profit | €158.60m |
Other Expenses | €181.90m |
Earnings | -€23.30m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 30, 2024
Earnings per share (EPS) | -0.13 |
Gross Margin | 10.16% |
Net Profit Margin | -1.49% |
Debt/Equity Ratio | 42.7% |
How did OKDBV perform over the long term?
See historical performance and comparison